Dr. Maria Donovan

Maria is a Lecturer in Clinical Pharmacy in UCC School of Pharmacy. Maria completed her PhD in 2016, in collaboration with INFANT, on the topic of optimising treatment of neonatal seizures. Her main area of research is the optimisation of dosing regimens in paediatric populations, which she undertakes in conjunction with the INFANT centre.

At present, Maria works as a Research Support Pharmacist on the IRELAND trial and is part of the In4Kids and conect4children clinical trials networks.

Relevant Publications:

Donovan, MD, Abduljalil, K, Cryan, JF, Boylan, GB, Griffin, BT. Application of a physiologically-based pharmacokinetic model for the prediction of bumetanide plasma and brain concentrations in the neonate. Biopharm Drug Dispos. 2018; 39: 125– 134.

Donovan, M.D., Griffin, B.T., Kharoshankaya, L. et al. Pharmacotherapy for Neonatal Seizures: Current Knowledge and Future Perspectives. Drugs 76, 647–661 (2016).

Donovan, M. D., Boylan, G. B., Murray, D. M., Cryan, J. F., and Griffin, B. T. (2016) Treating disorders of the neonatal central nervous system: pharmacokinetic and pharmacodynamic considerations with a focus on antiepileptics. Br J Clin Pharmacol, 81: 62– 77.  https://doi.org/10.1111/bcp.12753